M.J.T.M. Mol

EFFECTS OF SYNVINOLIN (MK-733) ON PLASMA LIPIDS IN FAMILIAL HYPERCHOLESTEROLAEMIA

M.J.T.M. Mol, J.A. Gevers Leuven, D.W. Erkelens et al. · The Lancet · 1986 · 156 citations

Metabolic Syndrome, Lipid Disorder, Effects Of Synvinolin +4

Plasma levels of lipid and cholesterol oxidation products and cytokines in diabetes mellitus and cigarette smoking: effects of vitamin E treatment

M.J.T.M. Mol, Yolanda B. de Rijke, Pierre N.M. Demacker et al. · Atherosclerosis · 1997 · 130 citations

Cholesterol Oxidation Products, Metabolic Syndrome, Nutrition +11

Enhanced Levels of Lipoperoxides in Low Density Lipoprotein Incubated with Murine Fibroblasts Expressing High Levels of Human 15-Lipoxygenase

D. Benz, M.J.T.M. Mol, Masanori Ezaki et al. · Journal of Biological Chemistry · 1995 · 107 citations · Full text

Modulation of very low density lipoprotein production and clearance contributes to age- and gender- dependent hyperlipoproteinemia in apolipoprotein E3-Leiden transgenic mice.

Bart J. van Vlijmen, H. Belinda van 't Hof, M.J.T.M. Mol et al. · Journal of Clinical Investigation · 1996 · 92 citations · Full text

Apolipoprotein E3-leiden, Genetics, Hyperlipidemia +21

Influence of apo E polymorphism on the response to simvastatin treatment in patients with heterozygous familial hypercholesterolemia

Peter De Kniiff, Anton F. H. Stalenhoef, M.J.T.M. Mol et al. · Atherosclerosis · 1990 · 82 citations

Lipid Disorder, Heterozygous Familial Hypercholesterolemia, Cardiovascular Disease +8